Nicotine Ameliorates α-synuclein Pre-formed Fibril-Induced Behavioral Deficits and Pathological Features in Mice

Zhangqiong Huang,Yue Pan,Kaili Ma,Haiyu Luo,Qinglan Zong,Zhengcun Wu,Zhouhai Zhu,Ying Guan
DOI: https://doi.org/10.1101/2024.05.09.593280
2024-05-10
Abstract:Epidemiologic study suggests nicotine reduces risk of PD, could be potential treatment for Parkinson's disease. To study the effect of nicotine on behavioral phenotypes and pathological characteristics of mice induced by human alpha-synuclein preformed fibers (alpha-syn-PFF). Mice were injected with 5ug of human alpha-syn-PFF in the hippocampus while administering nicotine-containing drinking water (200ug/mL). After 1 month, the motor ability, mood, spatial learning, and memory ability of the Parkinson's disease phenotype-like model were detected using open field, rotarod, Y maze, and O maze tests. The expression of pathological alpha-syn,apoptotic proteins and the numbers of glial cells and neural stem cells in the hippocampus of mice were detected using western blotting and immunofluorescence. These results suggest that nicotine significantly reduced pathological alpha-syn accumulation, alpha-syn serine 129 phosphorylation and cell death caused by PFF injection in the hippocampus of mice, inhibited the increase of glial, microglia and apoptotic cells, decreased the expression levels of PI3K and Akt, at the same time, exhibited significant memory impairment, motor deficits and anxiety-like behavior. In conclusion, our study suggests that nicotine may ameliorate behavioral deficits and pathological changes in mice by inhibiting human alpha-syn-PFF-induced neuroinflammation and apoptosis.
Animal Behavior and Cognition
What problem does this paper attempt to address?